BlackRock Japan’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$74K Buy
+971
New +$73.7K ﹤0.01% 914
2016
Q3
– Sell
-1,640
Closed -$135K – 1332
2016
Q2
$135K Buy
1,640
+588
+56% +$48.4K ﹤0.01% 862
2016
Q1
$80K Sell
1,052
-3,751
-78% -$278K ﹤0.01% 950
2015
Q4
$386K Buy
+4,803
New +$346K ﹤0.01% 765

Other funds holding CRL

BlackRock Japan's CRL Position: Q4 2016 in Review

BlackRock Japan opened a new position in Charles River Laboratories (CRL) in Q4 2016: 971 shares worth $74K. The stake represents ﹤0.01% of the portfolio and ranks #914 among its holdings. This is a return to the name: BlackRock Japan previously reported a position in CRL as recently as Q2 2016.

BlackRock Japan first reported a position in CRL in Q4 2015 and has held it in 4 quarters since. The position peaked at $386K in Q4 2015. 297 funds tracked by Wall St. Rank hold CRL as of Q4 2016.

  • BlackRock Japan held 971 shares of Charles River Laboratories worth $74K as of Q4 2016.
  • Charles River Laboratories was a new BlackRock Japan position in Q4 2016.
  • Charles River Laboratories made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #914 holding.
  • BlackRock Japan first reported a position in Charles River Laboratories in Q4 2015 and has held it in 4 quarters since.
  • BlackRock Japan's Charles River Laboratories position peaked at $386K in Q4 2015.
  • 297 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.